STOCK TITAN

Indaptus Therapeutics, Inc. (INDP) Net Income by Year

INDP

Indaptus Therapeutics, Inc. reported a net loss of $20.8M in fiscal year 2025. This represents a decrease of 38.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Indaptus Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$20.8M
YoY -38.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INDP Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-K
Net Income-$20.8M-38.8%-$15.0M+2.6%-$15.4M-7.7%-$14.3M-85.7%-$7.7M-115.2%-$3.6M

INDP Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$1.8M+65.7%-$2.5M+43.9%N/A-$3.0M+3.1%-$5.2M-30.2%-$4.5M-19.1%N/A-$3.1M+21.8%-$4.0M-23.7%-$3.8M+10.5%N/A-$3.9M-13.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Indaptus Therapeutics, Inc. financials

Frequently Asked Questions

What was Indaptus Therapeutics, Inc.'s net income in fiscal year 2025?

Indaptus Therapeutics, Inc. reported a net loss of $20.8M in fiscal year 2025.

How fast is Indaptus Therapeutics, Inc.'s net income growing?

Indaptus Therapeutics, Inc. (INDP) net income fell by 38.8% year over year, from -$15.0M to -$20.8M in fiscal year 2025.

How has Indaptus Therapeutics, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Indaptus Therapeutics, Inc. (INDP) net income went from -$3.6M in fiscal year 2020 to -$20.8M in fiscal year 2025.

Indaptus Therapeutics, Inc. (INDP) reported -$1.8M in net income in Q2 2026. This represents an increase of 65.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Indaptus Therapeutics, Inc. (INDP) reported on that line in every period on record.